PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.84%
Revenue growth above 1.5x RUN's 12.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
74.47%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
122.62%
EBIT growth above 1.5x RUN's 23.91%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
203.70%
Operating income growth above 1.5x RUN's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
159.66%
Net income growth under 50% of RUN's 460.66%. Michael Burry would suspect the firm is falling well behind a key competitor.
160.00%
EPS growth under 50% of RUN's 456.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
164.29%
Diluted EPS growth under 50% of RUN's 436.85%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.57%
Share reduction more than 1.5x RUN's 1.22%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.45%
Diluted share reduction more than 1.5x RUN's 1.26%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
143.24%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
88.10%
FCF growth 50-75% of RUN's 156.78%. Martin Whitman would see if structural disadvantages exist in generating free cash.
417.66%
10Y revenue/share CAGR above 1.5x RUN's 231.43%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
417.66%
5Y revenue/share CAGR above 1.5x RUN's 64.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
417.66%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-65.03%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-65.03%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-65.03%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
209.07%
Below 50% of RUN's 1473.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
209.07%
Below 50% of RUN's 1185.12%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
209.07%
3Y net income/share CAGR similar to RUN's 220.80%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.49%
AR growth well above RUN's 8.37%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.41%
Inventory shrinking or stable vs. RUN's 18.52%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
8.04%
Asset growth above 1.5x RUN's 4.18%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.78%
50-75% of RUN's 11.80%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
3.68%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
27.62%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.